Robotic Biopsy Devices Market To Reach $1.02 Billion By 2030

Robotic Biopsy Devices Market Growth & Trends

The global robotic biopsy devices market size is expected to reach USD 1.02 billion by 2030, according to a new report by Grand View Research, Inc., registering a 13.6% CAGR over the forecast period. Rising cancer incidence and increasing demand for minimally invasive surgeries are leading factors contributing toward this growth. Moreover, growing need for high precision while performing biopsies of delicate organs, without distressing surrounding nerves, is expected to drive the market.

On the basis of product type, robot-assisted biopsy devices are classified into systems and instruments & accessories. The systems segment is expected to grow at the fastest pace over the forecast period. Increasing launch of innovative biopsy robots and growing acquisition activities among key players have supported the growth of this segment. For instance, in September 2018, XACT Robotics received a CE mark for its robotics system, which gave the company entry into the European market. Moreover, in April 2019, Johnson & Johnson acquired robotic start-up Auris Health and obtained ownership of its Monarch Platform.

The lung biopsy segment dominated the market in terms of application, with a revenue of USD 132.4 million in 2018. Rising incidence of lung cancer worldwide and need for higher precision devices are some of the major factors driving the market. Robot assisted devices enable surgeons to access deep nodules within the lungs, that are too small and difficult to access manually. Moreover, this segment is expected to witness the fastest growth over the forecast period owing to continuous rise in the number of tobacco smokers in many Asian and European countries.

North America dominated the market in 2018, owing to high healthcare spending, presence of major robot manufacturers in this region, and growing penetration of robotic devices in healthcare settings. On the other hand, the Asia Pacific region is anticipated to grow at the fastest rate over the forecast period, owing to ongoing research and development on robotics in countries such as Japan and South Korea, and rising incidence of cancer in the region.

 Request a free sample copy or view report summary: Robotic Biopsy Devices Market Report

Robotic Biopsy Devices Market Report Highlights

• The instrument & accessories dominated the market and accounted for the largest revenue share of 55.9% in 2023 driven by technological advancements, enabling the development of more accurate and efficient robotic biopsy devices 

• The lung biopsy led the market and accounted for the largest revenue share of 44.1% in 2023. Developing lung disorders are common nowadays because the large population addicted to smoking, changing environmental conditions 

• The hospitals dominated the market and accounted for the largest revenue share of 69.1% in 2023 owing to a growing aging population, increasing prevalence of chronic diseases, and betterment in healthcare infrastructure 

• North America robotic biopsy devices market dominated the global market and accounted for the largest revenue share of 57.8% in 2023 attributed to the supporting reimbursement policies in the healthcare system

Robotic Biopsy Devices Market Segmentation

Grand View Research has segmented the global robotic biopsy devices market based on product, application, end-use and region:

Robotic Biopsy Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• System

• Instrument & Accessories

Robotic Biopsy Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Lung Biopsy

• Brain Biopsy

• Prostate Biopsy

• Other Biopsies

Robotic Biopsy Devices End use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient Facilities

Robotic Biopsy Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List Of Key Players in the Robotic Biopsy Devices Market

• Medical Device Business Services, Inc.

• Stryker

• Zimmer Biomet

• Smith+Nephew

• Medtronic

• Integra LifeSciences Corporation.

• Wright Medical Group N.V.

• Acumed LLC

• Bioretec GmbH

• Cardinal Health.